- $726.16m
- $387.03m
- $327.52m
- 85
- 43
- 49
- 62
Annual income statement for Riskified, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 170 | 229 | 261 | 298 | 328 |
| Cost of Revenue | |||||
| Gross Profit | 92.8 | 123 | 135 | 153 | 171 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 177 | 285 | 371 | 374 | 375 |
| Operating Profit | -6.81 | -55.9 | -109 | -76.8 | -47.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -10.3 | -178 | -98.7 | -53.2 | -28.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -11.3 | -179 | -105 | -59 | -34.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -11.3 | -179 | -105 | -59 | -34.9 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -11.3 | -179 | -105 | -59 | -34.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.072 | -1.09 | -0.623 | -0.333 | -0.198 |
| Dividends per Share |